Correlation Between Ideaya Biosciences and Janux Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ideaya Biosciences and Janux Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ideaya Biosciences and Janux Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ideaya Biosciences and Janux Therapeutics, you can compare the effects of market volatilities on Ideaya Biosciences and Janux Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ideaya Biosciences with a short position of Janux Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ideaya Biosciences and Janux Therapeutics.

Diversification Opportunities for Ideaya Biosciences and Janux Therapeutics

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Ideaya and Janux is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Ideaya Biosciences and Janux Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Janux Therapeutics and Ideaya Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ideaya Biosciences are associated (or correlated) with Janux Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Janux Therapeutics has no effect on the direction of Ideaya Biosciences i.e., Ideaya Biosciences and Janux Therapeutics go up and down completely randomly.

Pair Corralation between Ideaya Biosciences and Janux Therapeutics

Given the investment horizon of 90 days Ideaya Biosciences is expected to under-perform the Janux Therapeutics. In addition to that, Ideaya Biosciences is 1.17 times more volatile than Janux Therapeutics. It trades about -0.16 of its total potential returns per unit of risk. Janux Therapeutics is currently generating about -0.12 per unit of volatility. If you would invest  5,436  in Janux Therapeutics on August 27, 2024 and sell it today you would lose (405.00) from holding Janux Therapeutics or give up 7.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Ideaya Biosciences  vs.  Janux Therapeutics

 Performance 
       Timeline  
Ideaya Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ideaya Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Janux Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Janux Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Janux Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Ideaya Biosciences and Janux Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ideaya Biosciences and Janux Therapeutics

The main advantage of trading using opposite Ideaya Biosciences and Janux Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ideaya Biosciences position performs unexpectedly, Janux Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Janux Therapeutics will offset losses from the drop in Janux Therapeutics' long position.
The idea behind Ideaya Biosciences and Janux Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Stocks Directory
Find actively traded stocks across global markets